HeartMate Meets Its Match? HeartWare VAD Data Has Good Showing At AHA

Thoratec's days monopolizing the ventricular assist device market with its HeartMate VAD technology appear to be numbered. That's the consensus out of last week's American Heart Association annual meeting, where upstart HeartWare reported impressive results for its next-generation VAD in late-stage heart failure patients waiting for a transplant.